GlassScriptPhysician profile
Shannon H Fourtner
NPI 1225111651
$1,535.12
in general payments reported to CMS, 2019-2025
17 companies · $264 in 2025
The $264 reported for 2025 was less than what a typical Pediatric Endocrinology provider received nationally (typical 2025 total: $294).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $98.53 · 2021: $221 · 2022: $186 · 2023: $338 · 2024: $164 · 2025: $264.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $734 · Education: $32.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.45 |
| Education | $32.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $416.69 | 2019-2025 | |
| Novo Nordisk INC | $412.84 | 2020-2025 | Sogroya, Wegovy, Norditropin |
| Biomarin Pharmaceutical INC. | $169.84 | 2021-2025 | |
| Ultragenyx Pharmaceutical INC. | $109.61 | 2020-2022 | |
| Alexion Pharmaceuticals, INC. | $80.21 | 2019-2024 | Strensiq |
| Kyowa Kirin, INC. | $79.99 | 2023-2025 | Crysvita |
| Azurity Pharmaceuticals, INC. | $41.84 | 2023 | Triptodur |
| Tolmar Pharmaceuticals, INC. | $33.60 | 2020-2022 | |
| Ascendis Pharma Endocrinology INC | $25.28 | 2023 | |
| Neurocrine Biosciences, INC. | $24.77 | 2025 | |
| Dexcom, INC. | $24.26 | 2019 | |
| Nestle Healthcare Nutrition INC. | $23.91 | 2021 | |
| Medtronic Minimed, INC. | $20.49 | 2019 | |
| Eton Pharmaceuticals, INC. | $20.41 | 2021 | |
| Soleno Therapeutics, INC. | $19.72 | 2025 | Vykat Xr |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $19.52 | 2024 | Jardiance, Zepbound |
| Endo Pharmaceuticals INC. | $12.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shannon Fourtner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.